Protective immunity to chlamydial genital infection: Evidence from animal studies

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Rank, Roger G ^a   Whittum Hudson, Judith A ^b  

^a ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; CHLAMYDIASIS; EYE INFECTION; GENETIC DIFFERENCE; GENITAL TRACT INFECTION; GENOTYPE; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REINFECTION; REVIEW; SEROTYPE; TRACHOMA; ACTIVE IMMUNIZATION; ANIMAL; CHLAMYDIA; CLASSIFICATION; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; GYNECOLOGIC DISEASE; IMMUNOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CHLAMYDIA; CHLAMYDIA INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; GENITAL DISEASES, FEMALE; GENOTYPE; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; IMMUNITY, INNATE; PHENOTYPE;

EID: 77953102158     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652399     Document Type: Review

References (70)

1. Patton DL, Rank RG. Animal models for the study of pelvic inflammatory disease. In: Quinn TC, ed. Sexually transmitted diseases. New York, NY: Raven Press, 1992: 85-111.
2. Rank RG. Role of the immune response. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton, FL: CRC Press, 1988: 217-234.
3. Rank RG. Animal models for urogenital infections. In: Clark VL, Bavoil PM, eds. Bacterial pathogenesis. Part A: Identification and regulation of virulence factors. San Diego, CA: Academic Press, 1994: 83-92.
4. Rank RG. Models of immunity. In: Stephens RS, ed. Chlamydia: intracellular biology, pathogenesis, and immunity.Washington, DC: American Society for Microbiology, 1999: 239-295.
5. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun 2002; 70 (6): 2741-2751. (Pubitemid 34564127)
6. Rank RG. Chlamydial diseases. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, eds. The mouse in biomedical research. 2nd ed. New York, NY: Elsevier, 2007: 325-348.
7. Darville T, Hiltke T. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010; 201 (suppl 2): S114-S125 (in this supplement).
8. Barron AL, Rank RG, Moses EB. Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar). Infect Immun 1984; 44: 82-85.
9. Ramsey KH, Newhall WJ, Rank RG. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect Immun 1989; 57: 2441-2446.
10. Rank RG, Batteiger BE, Soderberg LSF. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun 1988; 56: 2243-2249.
11. Wolner-Hanssen P, Patton DL, Holmes KK. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991; 18: 21-25.
12. Johnson AP, Osborn MF, Thomas BJ, Hetherington CM, Taylor-Robinson D. Immunity to reinfection of the genital tract of marmosets with Chlamydia trachomatis. Br J Exp Pathol 1981; 62: 606-613.
13. Patterson TL, Rank RG. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1996; 23: 145-150.
14. Batteiger BE, Rank RG. Analysis of the humoral immune response in chlamydial genital infection in guinea pigs. Infect Immun 1987; 55: 1767-1773.
15. Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997; 65 (8): 3065-3073. (Pubitemid 27342379)
16. Rank RG, Sanders MM, Patton DL. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1995; 22 (1): 48-54.
17. Wolner-Hanssen P, Patton DL, Stamm WE, Holmes KK. Severe salpingitis in pig-tailed macaques after repeated cervical infections followed by a single tubal inoculation with Chlamydia trachomatis. In: Oriel D, Ridgway G, Schachter J, Taylor-Robinson D, Ward M, eds. Chlamydia infections. New York, NY: Cambridge University Press, 1986: 371-374.
18. Ramsey KH, Soderberg LSF, Rank RG. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 1988; 56: 1320-1325.
19. Su H, Morrison R, Messer R, Whitmire W, Hughes S, Caldwell HD. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis 1999; 180 (4): 1252-1258. (Pubitemid 30070211)
20. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl 1990; 69: 137-148. (Pubitemid 20333099)
21. Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a gambian cohort with frequent follow-up. PLoS Negl Trop Dis 2008; 2 (12): e341.
22. Taylor HR, Johnson SL, Prendergast RA, Schachter J, Dawson CR, Silverstein AM. An animal model of trachoma. II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci 1982; 23: 507-515.
23. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 1996; 173 (4): 950-956.
24. Arno JN, Katz BP, McBride R, et al. Age and clinical immunity to infections with Chlamydia trachomatis. Sex Transm Dis 1994; 21: 47-52.
25. Mount DT, Bigazzi PE, Barron AL. Experimental genital infection of male guinea pigs with the agent of guinea pig inclusion conjunctivitis and transmission to females. Infect Immun 1973; 8: 925-930.
26. Rank RG, Bowlin AK, Reed RL, Darville T. Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect Immun 2003; 71 (11): 6148-6154. (Pubitemid 37337668)
27. Lamont HC, Semine DZ, Leveille C, Nichols RL. Immunity to vaginal reinfection in female guinea pigs infected sexually with Chlamydia of guinea pig inclusion conjunctivitis. Infect Immun 1978; 19: 807-813.
28. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99 (1): 77-87.
29. Rank RG. Animal models: new research directions. In: Christiansen G, ed. Proceedings of the Sixth Meeting of the European Society for Chlamydia Research. 6th ed. Aarhus, Denmark: University of Aarhus, 2008: 85-91.
30. Barteneva N, Theodor I, Peterson EM, de la Maza LM. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun 1996; 64 (11): 4830-4833.
31. Tseng CK, Rank RG. Role of NK cells in the early host response to chlamydial genital infection. Infect Immun 1998; 66 (12): 5867-5875.
32. Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1979; 26: 573-579.
33. Rank RG, Barron AL. Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun 1983; 39: 463-465. (Pubitemid 13212554)
34. Rank RG, Barron AL. Prolonged genital infection by GPIC agent associated with immunosuppression following treatment with estradiol. In: Mardh PA, Holmes KK, Oriel JD, Piot P, Schachter J, eds. Chlamydial infections. New York, NY: Elsevier Biomedical Press, 1998: 391-394.
35. Rank RG, Batteiger BE. Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 1989; 57: 299-301.
36. Masson PL, Heremans JF, Ferin J. Clinical importance of the biochemical changes in the female genital tract. I. Studies on the proteins of cervical mucus. Int J Fertil 1969; 14: 1-7.
37. Su H, Feilzer K, Caldwell HD, Morrison RP. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 1997; 65 (6): 1993-1999.
38. + T cells. Infect Immun 2000; 68 (12): 6979-6987.
39. Morrison SG, Morrison RP. Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 2001; 69 (4): 2643-2649.
40. Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 2005; 175 (11): 7536-7542.
41. Howard LV. Neutralization of Chlamydia trachomatis in cell culture. Infect Immun 1975; 11: 698-703.
42. Su H, Caldwell HD. In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein. Infect Immun 1991; 59: 2843-2845.
43. Wyrick PB, Brownridge EA. Growth of Chlamydia psittaci in macrophages. Infect Immun 1978; 19: 1054-1060.
44. Rank RG, Soderberg LSF, Sanders MM, Batteiger BE. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1989; 57: 706-710.
45. Cain TK, Rank RG. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 1995; 63 (5): 1784-1789.
46. Igietseme JU, Rank RG. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun 1991; 59: 1346-1351.
47. Kelly KA, Rank RG. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intraaginal infection with Chlamydia trachomatis. Infect Immun 1997; 65: 5198-5208.
48. Hawkins RA, Rank RG, Kelly KA. Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun 2000; 68 (10): 5587-5594.
49. Taylor HR, Prendergast RA, Dawson CR, Schachter J, Silverstein AM. An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci 1981; 21: 422-433.
50. Caldwell HD, Stewart S, Johnson S, Taylor H. Tear and serum antibody responses to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun 1987; 55: 93-98.
51. Ghaem-Maghami S, Bailey RL, Mabey DCW, et al. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect Immun 1997; 65 (12): 4958-11964
52. Whittum-Hudson JA, Taylor HR, Farazdaghi M, Prendergast RA. Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest Ophthalmol Vis Sci 1986; 27: 64-69. (Pubitemid 16127673)
53. Reacher MH, Pe'er J, Rapoza PA, Whittum-Hudson JA, Taylor HR. T cells and trachoma: their role in cicatricial disease. Ophthalmology 1991; 98: 334-341.
54. Young E, Taylor HR. Immune mechanisms in chlamydial eye infection: development of T suppressor cells. Invest Ophthalmol Vis Sci 1986; 27: 615-619. (Pubitemid 16116312)
55. Barenfanger J, MacDonald AB. The role of immunoglobulin in the neutralization of trachoma infectivity. J Immunol 1974; 113: 1607-1617.
56. Wang SP, Grayston JT. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol 1967; 63: 1133-1145.
57. Whittum-Hudson JA, Taylor HR. Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection. Infect Immun 1989; 57: 2977-2983.
58. Pal S, Pu Z, Huneke RB, Taylor HR, Whittum-Hudson JA. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis. Reg Immunol 1990; 3: 171-176.
59. Pal S, Taylor HR, Huneke RB, Prendergast RA, Whittum-Hudson JA. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection. Infect Immun 1992; 60: 5294-5297.
60. Wang SP, Grayston JT. Classification of TRIC and related strains with microimmunofluorescence. In: Nichols RL, ed. Trachoma and related disorders caused by chlamydial agents. Amsterdam: Excerpta Medica, 1971: 305-321.
61. Ito JI Jr, Lyons JM, Airo-Brown LP. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990; 58: 2021-2023.
62. Ramsey KH, Cotter TW, Salyer RD, et al. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun 1999; 67 (6): 3019-3025.
63. Batteiger BE, Rank RG, Bavoil PM, Soderberg LSF. Partial protection against reinfection by immunization of guinea pigs with isolated outer-membrane proteins of the chlamydial agent of guinea pig inclusion conjunctivitis. J Gen Microbiol 1993; 139: 2965-2972. (Pubitemid 2029477)
64. Darville T, Andrews CW Jr, Sikes JD, Fraley PL, Braswell L, Rank RG. Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun 2001; 69 (12): 7419-7424. (Pubitemid 33086567)
65. de la Maza L, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994; 62: 2094-2097.
66. Bernstein-Hanley I, Coers J, Balsara ZR, Taylor GA, Starnbach MN, Dietrich WF. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci U S A 2006; 103 (38): 14092-14097.
67. Miyairi I, Tatireddigari VR, Mahdi OS, et al. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol 2007; 179 (3): 1814-1824.
68. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. J Infect Dis 2005; 192 (4): 591-599.
69. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008; 35 (1): 53-54.
70. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. Reply to Hagdu and to Moss et al. J Infect Dis 2006; 193: 1338-1339.